Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BIBP pentavalent vaccine
- Development stage
- Preclinical
- Lead developer
- Beijing Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The BIBP pentavalent vaccine is a polyvalent combination vaccine currently under development by the Beijing Institute of Biological Products (BIBP), a subsidiary of China National Biotec Group (CNBG) and Sinopharm. This vaccine is part of BIBP's strategic initiative to develop a diversified technology platform for combined and multivalent vaccines with independent intellectual property rights in China. While the specific antigen composition has not been publicly detailed, pentavalent vaccines typically provide immunization against five major pathogens: diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type B (Hib). The development of this vaccine aims to address urgent public health needs for simplified immunization schedules in the Chinese market.
- Other names
- Pentavaccine-Beijing Institute of Biological Products-polyvalent vaccinepentavaccinepentavalent vaccineBIBP pentavaccine
02
Targets
BCR (Immunoglobulin G B Cell Receptor)TT-BCR (Tetanus toxoid-specific B-cell receptor)
Beyond the preview
Go deeper on BIBP pentavalent vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIBP pentavalent vaccine.